Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C.

MLA

Propper, D. J., et al. “Phase I and Pharmacokinetic Study of PKC412, an Inhibitor of Protein Kinase C.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 19, no. 5, Mar. 2001, pp. 1485–92. EBSCOhost, https://doi.org/10.1200/JCO.2001.19.5.1485.

APA

Propper, D. J., McDonald, A. C., Man, A., Thavasu, P., Balkwill, F., Braybrooke, J. P., Caponigro, F., Graf, P., Dutreix, C., Blackie, R., Kaye, S. B., Ganesan, T. S., Talbot, D. C., Harris, A. L., & Twelves, C. (2001). Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 19(5), 1485–1492. https://doi.org/10.1200/JCO.2001.19.5.1485

Chicago

Propper, D J, A C McDonald, A Man, P Thavasu, F Balkwill, J P Braybrooke, F Caponigro, et al. 2001. “Phase I and Pharmacokinetic Study of PKC412, an Inhibitor of Protein Kinase C.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 19 (5): 1485–92. doi:10.1200/JCO.2001.19.5.1485.